Skip to main content

Table 1 Clinial characteristics of screened HCC patients

From: Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma

parameters patients, n(%)
Age (years)
  < 60 163 (67.1%)
  > =60 80 (32.9%)
Gender
 Female,n(%) 69 (28.4%)
 Male,n(%) 174((71.6%)
Grade
 1–2,n(%) 143 (58.8%)
 3–4,n(%) 100 (41.2%)
T grade
 T1–2,n(%) 182 (74.9%))
 T3–4,n(%) 61 (25.1%)
Risk score
 Low,n(%) 123 (50.6%)
 High,n(%) 120 (49.4%)
BMI
  < 24,n(%) 115 (47.3%)
  > =24,n(%) 128 (52.7%)
Race
 Asian,n(%) 126 (51.9%)
 Non-Asian,n(%) 117 (48.1%)
Other Tumor
 No,n(%) 225 (92.6%)
 Yes,n(%) 18 (7.4%)
Cancer status
 Tumor Free,n(%) 162 (66.7%)
 With Tumor,n(%) 81 (33.4%)
HCC risk factor
 No,n(%) 55 (22.6%)
 Yes,n(%) 188 (77.4%)
Surgical method
 Lobectomy,n(%) 94 (38.7%)
 Non-Lobectomy,n(%) 149 (61.3%)
Residual tumor
 R0,n(%) 230 (94.7%)
 No R0,n(%) 13 (5.3%)
New tumor event
 No,n(%) 105 (43.2%)
 Yes,n(%) 138 (56.8%)